AGN-229666 Ophthalmic Solution in Japanese Patients With Allergic Conjunctivitis

Summary

This study will evaluate the safety and efficacy of AGN-229666 for the prevention of allergen-mediated conjunctivitis.

Timeline

Start

2014-06-04

Primary completion

2014-12-20

Completion

2014-12-20

Publications

• Background Nakatani H, Gomes P, Bradford R, Guo Q, Safyan E, Hollander DA. Alcaftadine 0.25% versus Olopatadine 0.1% in Preventing Cedar Pollen Allergic Conjunctivitis in Japan: A Randomized Study. Ocul Immunol Inflamm. 2019;27(4):622-631. doi: 10.1080/09273948.2018.1432764. Epub 2018 Mar 15.

Drugs

Indications